Emerald Advisers’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-176,956	Closed	-$10.5M	–	285
2021 Q3	$10.5M	Buy	+176,956	New	+$10.5M	0.38%	96